Pharmaceutical formulations

Details for Australian Patent Application No. 2005222612 (hide)

Owner SmithKline Beecham plc

Inventors Matthews, Wayne M.; Margetson, Daniel N.; Brown, Adrian; McAllister, Stephen Mark; Raby, Ronald K. Jr.

Agent Davies Collison Cave

Pub. Number AU-B-2005222612

PCT Pub. Number WO2005/089726

Priority 60/552,499 12.03.04 US

Filing date 11 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 21 April 2011

International Classifications

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/089726 Priority application(s): WO2005/089726

21 April 2011 Application Accepted

  Published as AU-B-2005222612

18 August 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 19 Jul 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

8 December 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 19 Jul 2011

15 December 2011 Assignment before Grant

  SmithKline Beecham plc The application has been assigned to Capsugel Belgium NV

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005222613-Rapid acting drug delivery compositions

2005222608-Intranasal benzodiazepine compositions